MSDS

Bayer Environmental Science
SAFETY DATA SHEET
BAYER ADVANCED 3-IN-1 INSECT, DISEASE, & MITE
CONTROL CONCENTRATE
7/11
Version 3.0 / USA Revision Date: 05/05/2014
102000015315
Print Date: 05/05/2014
Acute oral toxicity
LD50 (female rat) > 2,000 mg/kg
Acute inhalation toxicity
LC50 (male/female combined rat) > 5.1 mg/l
Exposure time: 4 h
Determined in the form of a respirable aerosol.
(actual)
LC50 (male/female combined rat) > 20.4 mg/l
Exposure time: 1 h
Determined in the form of a respirable aerosol.
Extrapolated from the 4 hr LC50.
(actual)
Acute dermal toxicity
LD50 (male/female combined rat) > 4,000 mg/kg
Skin irritation
Slight irritation (rabbit)
Eye irritation
Minimally irritating. (rabbit)
Sensitisation
Non-sensitizing. (guinea pig)
Assessment repeated dose toxicity
Imidacloprid did not cause specific target organ toxicity in experimental animal studies.
Tau-fluvalinate did not cause specific target organ toxicity in experimental animal studies.
Tebuconazole did not cause specific target organ toxicity in experimental animal studies.
Assessment Mutagenicity
Imidacloprid was not mutagenic or genotoxic based on the overall weight of evidence in a battery of in
vitro and in vivo tests.
Tau-fluvalinate was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Tebuconazole was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Assessment Carcinogenicity
Imidacloprid was not carcinogenic in lifetime feeding studies in rats and mice.
Tau-fluvalinate was not carcinogenic in lifetime feeding studies in rats and mice.
Tebuconazole caused at high dose levels an increased incidence of tumours in mice in the following
organ(s): liver. The mechanism of tumour formation is not considered to be relevant to man.
ACGIH
None.
NTP
None.
IARC
None.
OSHA
None.
Assessment toxicity to reproduction
Imidacloprid caused reproduction toxicity in a two-generation study in rats only at dose levels also toxic